2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole
-
2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole
structure -
-
CAS No:
118343-19-4
-
Formula:
C13H17N3
-
Chemical Name:
2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole
-
Synonyms:
1H-Isoindole,2-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-;2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole;BRL 44408;2-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-1-methyl-1,3-dihydroisoindole;2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-1-methyl-2,3-dihydro-1H-isoindole
-
CAS No:
2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole Basic Attributes
331.37
215.29
Characteristics
27.6
0.97900
off-white solid
1.22±0.1 g/cm3(Predicted)
365.8±30.0 °C(Predicted)
175ºC
1.657
H2O: ~26 mg/mL, soluble
Desiccate at -20°C
1.53E-05mmHg at 25°C
Drug Information
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
1H-Isoindole, 2-((4,5-dihydro-1H-imidazol-2-yl)methyl)-2,3-dihydro-1-methyl-
2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole Use and Manufacturing
Selective α2A-adrenoceptor antagonist . Increases hippocampal noradrenaline release following systemic administration.
Computed Properties
Molecular Weight:215.29
XLogP3:0.8
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:2
Exact Mass:215.142247555
Monoisotopic Mass:215.142247555
Topological Polar Surface Area:27.6
Heavy Atom Count:16
Complexity:287
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
2-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-2,3-dihydro-1-methyl-1H-isoindole
SDSRequest for Quotation